3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Motor Activity
32
Breast Neoplasms
21
Neoplasms
16
Prostatic Neoplasms
11
Obesity
8
Sarcopenia
6
Colorectal Neoplasms
6
Pancreatic Neoplasms
5
Lung Neoplasms
5
Head and Neck Neoplasms
5
Polycystic Ovary Syndrome
4
Signs and Symptoms
3
Multiple Myeloma
3
Lymphedema
3
Inflammation
3
Fatigue
3
Diabetes Mellitus, Type 2
3
Colonic Neoplasms
3
Brain Neoplasms
3
Uterine Cervical Neoplasms
2
Pharyngeal Neoplasms
2
Overweight
2
Osteoporosis, Postmenopausal
2
Osteoporosis
2
Lymphoma
2
Leukemia
2
Laryngeal Neoplasms
2
Insulin Resistance
2
Hematopoietic and Lymphatic System Neoplasm
2
Endometrial Neoplasms
2
Interventions
Radiotherapy
2
Exercise
2
Deglutition
2
Cisplatin
2
Carboplatin
2
Brachytherapy
2
Acupuncture Therapy
2
tislelizumab
1
epigallocatechin gallate
1
dexamethasone acetate
1
dexamethasone 21-phosphate
1
auricularum
1
Tablets
1
Standard of Care
1
Resistance Training
1
Range of Motion, Articular
1
Radiotherapy, Intensity-Modulated
1
Radiation
1
Pravastatin
1
Paclitaxel
1
Niacinamide
1
Musculoskeletal Manipulations
1
Lead
1
Hyaluronic Acid
1
Gastropexy
1
Fundoplication
1
Fluorouracil
1
Fibroblast Growth Factor 7
1
Esophagectomy
1
Endoscopy, Digestive System
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Deglutition Disorders
×
Resistance Training
×
Clear all
NCT02385929
2020-03-27
SYNK
Rigshospitalet, Denmark
Phase NA
Completed
240 enrolled